BBS-Bioactive Bone Substitutes

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

MARKN.

BBS-Bioactive Bone Substitutes Plc | Company Release | June 05, 2024 at 13:00:00 EEST

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd

BBS-Bioactive Bone Substitutes Plc ("BBS") has received 4th June 2024 requests from Riverfort Global Opportunities PCC Ltd ("Riverfort") to convert a proportion of EUR 70,000 of the convertible notes into Company shares at a conversion price of EUR 0.32634 per share. The conversion shall be executed by transferring a total of 214,500 treasury shares to Riverfort.

The Conversion price according to the terms and conditions is “90% of the lowest volume weighted average price of a trading day during ten trading days before the applicable subscription notice“.

After the transfers, the Company will hold a total of 2,147 treasury shares in its possession.

Datum 2024-06-05, kl 12:00
Källa MFN
200 kr till alla nya kunder! Just nu får alla nya kunder på Nordnet 200 kronor insatta i fonden Nordnet One Offensiv. Erbjudandet gäller mellan 1:e och 30:e september!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet